Cathie Wood Chemomab Therapeutics Ltd. Transaction History

Ark Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$2.58 - $4.88 $2,043 - $3,864	-792 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$3.53 - $7.2 $940,745 - $1.92 Million	-266,500 Reduced 99.7%	792 $4,000
Q4 2021 Jan 28, 2022	BUY	$6.41 - $11.13 $556,189 - $965,738	86,769 Added 48.07%	267,292 $1.84 Million
Q3 2021 Nov 12, 2021	BUY	$11.08 - $19.17 $2 Million - $3.46 Million	180,523 New	180,523 $2 Million

4.55M

Ticker CMMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,431,700
Market Cap $19.2M
Description
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.